Mbx Biosciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
MBX Biosciences, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 4, 2026, to elect directors and ratify auditors.
NASDAQ
MBX Biosciences announces its 2025 Annual Meeting of Stockholders to be held on June 5, 2025, featuring the election of directors and ratification of the company's independent auditor.
NASDAQ
MBX Biosciences will hold its 2025 Annual Meeting of Stockholders virtually on June 5, 2025, to elect directors and ratify the appointment of Ernst & Young LLP as its independent auditor.